In this issue:
Capsule for detecting labile inflammatory biomarkers in the GI tract
Molecular point-of-care testing for GI pathogens in suspected gastroenteritis
Pegozafermin for NASH
Nonerosive GORD and oesophageal adenocarcinoma incidence
Age at NAFLD onset and cancer risk
Surveillance system for follow-up after colorectal polypectomy
Targeting HBV with small interfering RNA and capsid assembly modulator agents
Type 2 diabetes, hepatic decompensation and hepatocellular carcinoma in NAFLD
PPI use and metachronous gastric cancer risk after H. pylori eradication
Predictors of histological response to mepolizumab in paediatric eosinophilic oesophagitis
Please login below to download this issue (PDF)